Back to search
FDAFDA · Food and drugs·Recall number D-0624-2024

Progesterone Injection, USP, 500 mg per 10 mL (50mg/mL), 10 mL Multiple-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E Windsor, NJ 08520, NDC 55150-306-10.

Published August 7, 2024 · Recall initiated: July 26, 2024

Summary

FDA records drug Class II recall D-0624-2024, published August 7, 2024 and initiated July 26, 2024. Recalling firm: Eugia US LLC; Status: Ongoing; Reported quantity: 17136 vials; Lot: Lot #: CPR230029A. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Particulate Matter: Complaint received of a glass particle in the vial.

What to do

Voluntary: Firm initiated

Get an email if PROGESTERONE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
PROGESTERONE
Manufacturer
Eugia US LLC
Distributor
Nationwide in the USA
Lot
Lot #: CPR230029A
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Progesterone Injection, USP, 500 mg per 10 mL (50mg/mL), 10 mL Multiple-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E Windsor, NJ 08520, NDC 55150-306-10. recalled?

Yes. FDA published recall D-0624-2024 on August 7, 2024. Reported hazard: Presence of Particulate Matter: Complaint received of a glass particle in the vial.

What should I do if I have this product?

Voluntary: Firm initiated

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: PROGESTERONE.